Yan‐jun Zhang, Kenichi Ikejima, Hajime Honda, Tsuneo Kitamura, Yoshiyuki Takei, Nobuhiro Sato – 30 December 2003 – Apoptosis of sinusoidal endothelial cells (SECs) is one of the initial events in the development of ischemia‐reperfusion injury of the liver. Glycine has been shown to diminish ischemia‐reperfusion injury in the liver and improve graft survival in the rat liver transplantation model. Here, we investigated the effect of glycine on apoptosis of primary cultured rat SECs induced by vascular endothelial growth factor (VEGF) deprivation.

Michael Malinchoc, Patrick S. Kamath – 30 December 2003

Raghavakaimal Sreekumar, Alvaro Gonzalez‐Koch, Yaakov Maor‐Kendler, Kenneth Batts, Laura Moreno‐Luna, John Poterucha, Lawrence Burgart, Russell Wiesner, Walter Kremers, Charles Rosen, Michael R. Charlton – 30 December 2003 – Approximately half of patients undergoing liver transplantation (LT) for hepatitis C virus (HCV) develop histologic evidence of recurrence within the first postoperative year. Early identification of recipients at risk for more severe recurrence of HCV may be useful in selecting patients for antiviral therapy.

Philippe Mathurin, Qing‐Gao Deng, Ali Keshavarzian, Sandeep Choudhary, Earle W. Holmes, Hidekazu Tsukamoto – 30 December 2003 – Increased gut permeability (leaky gut) and endotoxin‐mediated Kupffer cell activation are proposed as the mechanisms of alcoholic liver injury. Although ethanol feeding is shown to sensitize the liver for injury induced by parental administration of lipopolysaccharide (LPS), how enteral LPS loading affects alcoholic liver injury is yet to be tested.

Eiji Tanaka, Chiharu Ohue, Katsumi Aoyagi, Kenjiro Yamaguchi, Shintaro Yagi, Kendo Kiyosawa, Harvey J. Alter – 30 December 2003 – The aim of this study was to analyze the clinical performance of a new enzyme immunoassay (EIA) for hepatitis C virus (HCV) core antigen in comparison with the reverse transcription polymerase chain reaction (RT‐PCR). A total of 310 patients with acute or chronic hepatitis C, and 132 HCV‐negative controls were studied.

Stuart C. Gordon, Jane W. Fang, Ann L. Silverman, John G. McHutchison, Janice K. Albrecht – 30 December 2003 – We sought to determine whether pretreatment serum alanine aminotransferase (ALT) levels in patients with chronic hepatitis C virus (HCV) correlate with demographic features and other disease characteristics and whether these values influence response to therapy. A total of 1,744 patients with HCV received either interferon alfa‐2b and placebo or combination interferon alfa‐2b and ribavirin for 24 or 48 weeks.

Antony J. Ellis, Julia A. Wendon, Roger Williams – 30 December 2003 – Subclinical seizure activity in the patient with encephalopathy and on ventilation with acute liver failure (ALF) is a poorly recognized entity. Its importance lies in the likely exacerbation of cerebral hypoxia and the contribution of such seizure activity to the development of cerebral edema.

Keith R. Loeb, Keith R. Jerome, James Goddard, Meei‐li Huang, Anne Cent, Lawrence Corey – 30 December 2003 – Reproducible quantitative assays to detect viral nucleic acids have proven useful in defining disease progression and following response to therapy in a wide variety of viral infections. We describe the development of a quantitative assay to detect hepatitis B virus (HBV) DNA using real‐time fluorescent‐probe polymerase chain reaction (PCR) (TaqMan).

Andy S. Yu, Emmet B. Keeffe – 30 December 2003

Etsuro Orito, Masashi Mizokami, Hiroshi Sakugawa, Kojiro Michitaka, Kazuyoshi Ishikawa, Takafumi Ichida, Takeshi Okanoue, Hiroshi Yotsuyanagi, Shiro Iino – 30 December 2003 – Clinical and molecular virological differences were evaluated in 50 Japanese patients chronically infected with HBV of genotype B and C who were matched for age and sex as well as the severity of liver disease in a case‐control study. Hepatitis B e antigen (HBeAg) was significantly less frequent (16% vs. 42%, P < .01), whereas antibody to HBeAg (anti‐HBe) was significantly more common (84% vs.